Neuroinflammation-on-a-chip for multiple sclerosis research: a narrative review

• Published in: Annals of medicine and surgery Vol. 86; no. 7; pp. 4053 - 4059
• Main Authors: Berjaoui, Christin, Kachouh, Charbel, Joumaa, Safaa, Hussein Ghayyad, Mohammad, Abate Bekele, Bisrat, Ajirenike, Rita, Al Maaz, Zeina, Awde, Sara, Wojtara, Magda, Nazir, Abubakar, Uwishema, Olivier
• Format: Journal Article
• Language: English
• Published: England Lippincott Williams & Wilkins 01-07-2024
• Subjects: Reviews; neuroinflammation; chip; multiple sclerosis
• ISSN: 2049-0801; 2049-0801
• DOI: 10.1097/MS9.0000000000002231

Multiple sclerosis (MS) is a chronic inflammatory condition that impacts the central nervous system. It is distinguished by processes like demyelination, gliosis, neuro-axonal harm, and inflammation. The prevailing theory suggests that MS originates from an immune response directed against the body's own antigens within the central nervous system.
The main aim of this research paper "Neuroinflammation-on-a-Chip" for studying multiple sclerosis is to enhance our comprehension of MS development, demonstrate the application of cutting-edge technology, and potentially provide valuable insights for therapeutic approaches.
The available literature for this Narrative Review was searched on various bibliographic databases, PubMed, NCBI, and many other medical references using an individually verified, prespecified approach. Studies regarding the significance of MS and its neuroinflammatory pathogenesis in addition to the development and optimization of neuroinflammatory-on-a-chip and the advancement in innovations in this field have been reviewed in this research for a better understanding of "Neuroinflammation-on-a-chip for multiple sclerosis". The level of evidence of the included studies was considered as per the Centre for Evidence-Based Medicine recommendations.
Several studies have indicated that the brain-chip model closely mimics cortical brain tissue compared to commonly used conventional cell culture methods like the Transwell culture system. Additionally, these studies have clearly demonstrated that further research using brain chips has the potential to enhance our understanding of the molecular mechanisms and roles of blood-brain barrier (BBB) transporters in both normal and disease conditions.
Understanding neuroinflammation processes remains essential to establish new MS treatments approaches. The utilization of brain chips promises to advance our understanding of the molecular processes involving BBB transporters, both in normal and diseased states. Further research needs to be addressed in order to enhance the performance and understanding of neuroinflammation on a chip, hence aiming to provide more effective treatments for all CNS diseases.